GrantQuick

health · HHS-NIH11

Metastasis Research Network (U54 Clinical Trial Not Allowed)

National Institutes of Health · RFA-CA-27-012

36 days left

Award Range

$0$1.3M

Total Program Funding

$6.8M

Expected Awards

4

Deadline

September 25, 2026

GRANTQUICK SUMMARYPlain-English Overview

Metastasis Research Network (U54 Clinical Trial Not Allowed). National Institutes of Health. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to... up to $1,300,000 per award; $6,800,000 total program funding; ~4 awards expected.

Who Should Apply

City/township governments, Public And Indian Housing Authorities, For-profit organizations, Nonprofits (501c3), Public universities/colleges (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • Refer to Section III
  • Deadline: 2026-09-25

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.

Attachments

Who Can Apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Eligible Applicant Types

City/Township GovernmentsPublic And Indian Housing AuthoritiesFor-Profit Organizations501(c)(3) NonprofitsPublic Colleges & UniversitiesIndependent School DistrictsPrivate Colleges & UniversitiesFederally Recognized Tribal GovernmentsNonprofits without 501(c)(3)Other Tribal OrganizationsSpecial District GovernmentsOther (see NOFO for details)Small BusinessesState GovernmentsCounty Governments

Funding Details

Maximum Award
$1.3M
Total Program Funding
$6.8M
Expected Number of Awards
4
Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: June 4, 2026
Application Deadline: September 25, 2026 (36 days remaining)

Agency Contact

NCI MetNet Research Program NCIMetNet@mail.nih.gov

NCIMetNet@mail.nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov